Abstract | BACKGROUND: Many agents are available for treating epilepsy; however, population studies have failed to show overall differences in efficacy for a given seizure type. Clinical experience suggests that certain individuals will respond to a given agent while others with the same seizure type will not. OBJECTIVES: To examine a population of patients who received one of the newer antiepileptic drugs, levetiracetam, and to identify those who had either a dramatic improvement or a significant worsening of seizures. METHODS: RESULTS: Patients who responded well to levetiracetam therapy were older at the onset of epileptic seizure than those who did not (mean [SD] age, 51 [5] vs 27 [3] years; P<.05). This was also true of the subset of patients who had localization-related epilepsy. Patients with temporal lobe onset were likely to do well whereas patients with frontal lobe onset were not. CONCLUSIONS: These results suggest that certain subpopulations may be particularly likely to respond to levetiracetam therapy. These need to be confirmed in a larger prospective trial; however, looking for specific characteristics of patients who respond to certain drugs may lead to useful guidelines for drug choices in treating epilepsy.
|
Authors | Carl W Bazil, Andrew Rose, Stanley Resor, Bülent Yapicular, Lawrence J Hirsch |
Journal | Archives of neurology
(Arch Neurol)
Vol. 59
Issue 12
Pg. 1905-8
(Dec 2002)
ISSN: 0003-9942 [Print] United States |
PMID | 12470178
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Anticonvulsants
- Levetiracetam
- Piracetam
|
Topics |
- Adult
- Age of Onset
- Anticonvulsants
(therapeutic use)
- Epilepsies, Partial
(drug therapy, physiopathology)
- Female
- Humans
- Levetiracetam
- Male
- Middle Aged
- Neuropsychological Tests
(statistics & numerical data)
- Piracetam
(analogs & derivatives, therapeutic use)
- Postoperative Period
- Preoperative Care
(statistics & numerical data)
- Retrospective Studies
- Verbal Learning
|